GENERAL ATLANTIC L P's Q4 2025 13F: 1 new position, 4 exits

Form 13F-HR for the quarter ended Dec 31, 2025 · filed Feb 17, 2026 · 13 reported positions · accession 0000950142-26-000395

What changed this quarter

GENERAL ATLANTIC L P's changes in reported equity positions, Q4 2025
Activity Security Weight before Weight now Change Shares Shares %
Exited AKERO THERAPEUTICS (AKRO) 8.2% — −8.2 pts −5.73M sh −100%
Reduced ALIGNMENT HEALTHCARE (ALHC) 12.7% 9.1% −3.7 pts −11.12M sh −46%
New NURIX THERAPEUTICS (NRIX) — 3.2% +3.2 pts +4.9M sh new
Reduced CENTESSA PHARMACEUTICALS (CNTA) 7.0% 5.3% −1.7 pts −3.56M sh −37%
Reduced WEBULL (BULL) 3.2% 0.0% −3.2 pts −7.15M sh −99%
Increased CHIME (CHYM) 11.6% 18.6% +7.0 pts +2.05M sh +11%
Reduced XP, INC (XP) 14.4% 12.9% −1.5 pts −2.82M sh −11%
Exited ROYALTY PHARMA (RPRX) 1.6% — −1.6 pts −1.5M sh −100%
Increased REVOLUTION MEDICINES (RVMD) 3.5% 7.8% +4.3 pts +339K sh +14%
Exited ADAGENE (ADAG) 0.2% — −0.2 pts −3.78M sh −100%
Exited ALUMIS (ALMS) 0.2% — −0.2 pts −1.3M sh −100%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 99.0% of the equity book

Changes in the top 10 this quarter: NRIX entered · EWCZ entered · AKRO left · BULL left

# Security Weight before Weight now
1 DLOCAL (DLO) 20.0% 23.0%
2 CHIME (CHYM) 11.6% 18.6%
3 XP, INC (XP) 14.4% 12.9%
4 ALKAMI (ALKT) 8.9% 9.6%
5 ALIGNMENT HEALTHCARE (ALHC) 12.7% 9.1%
6 REVOLUTION MEDICINES (RVMD) 3.5% 7.8%
7 PHARVARIS (PHVS) 6.0% 7.8%
8 CENTESSA PHARMACEUTICALS (CNTA) 7.0% 5.3%
9 NURIX THERAPEUTICS (NRIX) 0.0% 3.2% Entered the top 10
10 EUROPEAN WAX CENTER (EWCZ) 1.6% 1.6% Entered the top 10
— AKERO THERAPEUTICS (AKRO) 8.2% 0.0% Left the top 10
— WEBULL (BULL) 3.2% 0.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).